Wednesday, 7 January 2015

Paratek to Receive $4 Million Payment From Actavis With Initiation of Phase 3 Trial of Sarecycline

<b>http://tinyurl.com/bxfmauj - <a href='http://tinyurl.com/bxfmauj'>6 New Things I Learned in 2014</a></b><p>They are very distinctive from other birds because of their black bodies with white heads and tail feathers - very easy to identify from the ground. BUT---immature eagles, up to about three years, are all black. They are also not quite as large as the ...</p><B>Paratek to Receive $4 Million Payment From Actavis With Initiation of Phase 3 ...</b><p>Acne vulgaris is a chronic inflammatory dermatosis which is notable for open and/or closed comedones (blackheads and whiteheads) and inflammatory lesions including papules, pustules, or nodules. Acne occurs most commonly during adolescence and&nbsp;...and more&nbsp;&raquo;</p><B>Paratek to Receive $4 Million Payment From Actavis With Initiation of Phase 3 Trial of Sarecycline</b><p>BOSTON Paratek Pharmaceuticals, Inc. today announced Actavis will be making a $4 million milestone payment to Paratek under the terms of the part
ies&#39; collaboration for the development of sarecycline ...</p>

No comments:

Post a Comment